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ABSTRACT
Paleogenetics offers a unique opportunity to study human evolution, population dynamics, and disease evolution
in situ. Although histologic and computed x-ray tomographic investigations of ancient mummies have clearly
shown that atherosclerosis has been present in humans for more than 5,000 years, limited data are available
on the presence of genetic predisposition for cardiovascular disease in ancient human populations. In a
previous whole-genome study of the Tyrolean Iceman, a 5,300-year-old glacier mummy from the Alps, an
increased risk for coronary heart disease was detected. The Iceman’s genome revealed several single
nucleotide polymorphisms that are linked with cardiovascular disease in genome-wide association studies.
Future genetic studies of ancient humans from various geographic origins and time periods have the potential
to provide more insights into the presence and possible changes of genetic risk factors in our ancestors. The
study of ancient humans and a better understanding of the interaction between environmental and genetic
influences on the development of heart diseases may lead to a more effective prevention and treatment of the
most common cause of death in the modern world.
Soon after Watson and Crick were awarded the Nobel
Prize in 1962 for describing the structure of deoxy-
ribonucleic acid (DNA), another Nobel Prize winner, Linus
Pauling, coined the term “paleogenetics,” proposing that
polypeptide sequences of ancient and extinct creatures
might be reconstructed by sequencing their DNA [1].
Michael Crichton popularized this concept in his 1990
novel Jurassic Park, purporting to recreate dinosaurs from
DNA extracted from dinosaur blood ingested by million-
year-old mosquitos preserved in amber, a preposterous
but intriguing application of technology that, in real life,
has led to the decoding of DNA from ancient humans,
including extinct forms such as Neanderthals and Deni-
sovans and ancient modern humans including Egyptian
and other mummies.
Since the first ancient DNA studieswere performed about
30 years ago [2,3], the field has significantly changed from the
retrieval of small DNA fragments from single specimens to
large-scale genome-wide studies of past populations [4].
These studies enable wide-ranging research in human evo-
lution and ancestry [5], population dynamics including past
migration patterns [6,7], and insights into phenotype, such as
skin and eye color [8]. Paleogenetic analysis of ancient DNA
samples can further detect the presence of bacteria and par-
asites, documenting infections such as tuberculosis, malaria,
and Lyme disease in ancient human populations [9e11].
Moreover, advances in DNA recovery and sequencing allow
full genome investigation of ancient pathogens that lead to
new insights into disease evolution. The combination of DNA
array capture and next-generation sequencing technologies
allowed the reconstruction of complete bacterial genomes of
Yersinia pestis andMycobacterium leprae strains fromMedieval
Europe, showing a remarkable genetic conservation of both
pathogens throughout the last 1,000 years [12e14].
Work with ancient DNA is limited by factors that reduce
the possibility of detecting ancient geneticmaterial. Onemain
factor is the degradation of DNA that initiates immediately
after the death of an organism. The activity of enzymes and
microorganisms lead to a significant fragmentation of the
DNA molecules and a reduction of the overall DNA amount.
This process is further enhanced by hydrolytic and oxidative
processes that can also result in destabilization andmiscoding
of the DNA by deamination and depurination. These factors
can severely disturb the polymerase chain reaction amplifi-
cation severely leading to nonspecific products or incorrect
sequences [15]. Several parameters such as high temperature,
ultraviolet radiation, humidity, and a low pH value signifi-
cantly accelerate the DNA decay [16,17]. In contrast, a dry
and cool climate or rapid desiccation of an organism due to
artificial or natural mummification may slow down the
degradation process, increasing the probability of ancient
DNA preservation. In any case, the amount of authentic DNA
in ancient tissue samples is generally very low or may have
disappeared completely.
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Despite these limitations, given favorable conditions such
as permafrost, soil DNA may survive up to 800,000 years in
the case of Pleistocene fauna [18] or 400,000 years for hom-
inin fossils from the Iberian Peninsula [19]. Besides the state of
preservation of the specimens, the risk of contamination with
modern human DNA is a major limitation in ancient DNA
studies. Therefore, strict rules to avoid contamination have
been introduced that are now compulsory for ancient DNA
analysis. The use of specially designated laboratories with
physically isolated work areas, extraction, and polymerase
chain reaction control amplifications but no positive control
samples, repeated amplifications of the same or several ex-
tracts, inverse correlation between amplification efficiency
and length of amplification (appropriate molecular behavior),
and independent replication can be regarded as basic and
essential for any kind of ancient DNA study. Quantitation of
the number of amplifiable DNA molecules in a sample is
especially important for human DNA studies, but seems to
be of minor relevance for paleomicrobiological studies
[15,20,21].
Polymerase chain reactionebased approaches are still
hampered by the risk of amplifying exogenous contaminants
and the highly fragmented endogenous DNA [15]. In
contrast, new high-throughput sequencing technologies
including targeted enrichment strategies allow the recon-
struction of full genomes [13], even from samples with
mixed metagenomic information. In addition, DNA degra-
dation patterns that accumulate over time are now
commonly used to test the authenticity of ancient DNA
[22,23].
It was widely accepted that biochemical assays of
macromolecular preservation are good indicators for the
presence of ancient DNA in a specimen. Usually, the total
amount of amino acids, the composition of amino acids,
and their extent of racemization have been used to estimate
the probability of ancient DNA survival. In a recent study,
Collins et al. [24] provided new evidence that the extent
of aspartic acid racemization seems not to be a useful
screening technique for ancient DNA from bone, as they
have found no correlation between the extent of aspartic
acid racemization and DNA amplification success. This
finding clearly contrasts with the assumptions from pre-
vious studies underlining the necessity to critically review
this authentication criterion.
Taken together, the application of strict authenticity
criteria is necessary andmust be the basis of any ancient DNA
study. This does not, however, substitute for proper study
design and background knowledge, which allow successful
retrieval of ancient DNA.
Recent genomic studies in contemporary humans are
revealing a growing number of single nucleotide poly-
morphisms (SNP) that predispose to the development of
atherosclerotic cardiovascular disease [25e27]. In partic-
ular, SNP located on chromosome 9p21 show a strong
association with cardiovascular disease. Modern genomics
has limited capacity to study past human genetic diversity in
order to understand the evolutionary history of the modern
human genome. It is clear from histologic and computed
x-ray tomographic investigations of ancient mummies that
atherosclerotic cardiovascular diseases have been present in
humans for at least 5,000 years, affecting individuals with
widely differing lifestyles and environments over a broad
geographic and temporal range [28e30]. Studies of DNA
extracted from ancient mummies permit a better under-
standing of the evolution and history of atherosclerosis.
ÖTZI THE ICEMAN
On September 19, 1991, a naturally mummified body,
later called Iceman, or commonly referred to as “Ötzi,” was
discovered in the Ötztal Alps at an altitude of 3,210 m
(Fig. 1). The Iceman lived around 3,300 BC and died at an
age of approximately 40 to 50 years [31]. The mummy is
now housed together with his belongings at the South
Tyrolean Museum of Archaeology in Bolzano, Italy (Figs. 2
and 3). The extraordinary well-preserved body and the
preservation of his clothing and equipment allowed unique
insights into the living circumstances of early Copper Age
humans in the alpine region [32,33]. Since his discovery in
1991, this mummy has undergone extensive scientific
studies using a wide range of methodologies, including
radiology and computed tomography, histology, isotope
analysis, paleobotany, and genetic analysis. In the last few
years, several advanced contemporary technologies have
been applied to study the glacier mummy. These include
nanotechnological analysis of soft tissue and bone samples,
spectroscopy of blood remnants in his clothing, a reeval-
uation of radiological data, and a detailed genetic analysis
of the nuclear genome (Fig. 4) [11,34,35].
Based on stable isotope analysis, it was shown that the
Iceman grew up and lived the last years before his death
in different valleys in the southern region of the Alps [36].
A paleobotanical study and pollen analyses of samples
removed from his intestines have provided important
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FIGURE 1. The discovery site of the Iceman in the Ötztal
Alps (South Tyrol, Italy). The glacier mummy was found in
a 40-melong, 2.5- to 3-medeep and 5- to 8-mewide
rocky gully at the Tisenjoch, 3,210 m above sea level.
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insights into his nutrition, his last itinerary, and the season of
his death in late spring [37,38]. Computed tomography (CT)
scans demonstrate the presence of healed rib fractures,
degenerative arthritis, some degree of vascular calcification,
and the presence of an arrowhead in his left shoulder
[39,40]. A recent multislice CT examination performed in
2007 clearly demonstrated that the arrowhead had lacerated
the left subclavian artery, likely leading to a rapid, deadly
hemorrhagic shock (Fig. 5). It could be further shown that
the Iceman suffered from a severe brain injury that could
have been caused shortly after or before the deadly arrow-
shot [41,42]. In a recent reevaluation of the CT scans, further
details on the life and death of the Iceman were revealed,
including the presence of gallbladder stones and a
completely full stomach [35].
In the years immediately after the retrieval of the Iceman,
the initial genetic studies of his mitochondrial DNA were
initiatedwith the analysis of the so-called hypervariable region
[43]. In later years, the entire mitochondrial genome was
successfully analyzed [44]. In a recent study, the whole
nuclear genomewas analyzed from a small bone sample of the
Iceman. The next-generation sequencing approach revealed
about 40% reads that mapped unambiguously to the human
reference genome and, thereby, an overall coverage of the
human genome of more than 80% was retrieved. The
authenticity of the ancient Iceman DNA was confirmed by
a comparison with the previously published mitochondrial
DNA that revealed full concordance.
The whole genome approach revealed many interesting
insights into physiological parameters, diseases, and the
ancestry of the Iceman, it could be shown that he likely had
brown eyes, in contrast to the previous assumption that he
had blue eyes (Fig. 6). It could be further shown that the
Iceman was lactose intolerant, a characteristic that is among
the most significant genetic traits connected with the
beginning of agriculture in Europe. The study further pro-
vided indications for recent common ancestry between the
Iceman and present-day inhabitants of the area near the
Tyrrhenian Sea.
The Iceman genome underwent a further detailed anal-
ysis of genetic risk factors, specifically for DNA sequence
variations, so-called SNP that are linked with diseases. The
most intriguing finding was that the Iceman showed a strong
genetic predisposition for increased risk for coronary heart
disease (CHD). This is of particular interest as the CT scans
of the Iceman already had revealed major calcification in ca-
rotid arteries, distal aorta, and right iliac artery, which are
strong signs of generalized atherosclerotic disease (Fig. 6)
[35,40]. The genetic predisposition could have significantly
FIGURE 4. Sampling of the Iceman for genetic analyses
under sterile conditions.
FIGURE 3. An automated refrigeration system is used
for the conservation of the Iceman.
FIGURE 2. The well-preserved mummy housed in the
South Tyrolean Museum of Archeology in Bolzano, Italy.
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contributed to the development of the arterial calcifications.
Other traditional cardiac risk factors, such as overweight, to-
bacco smoking, lack of physical activity, and a high fat diet,
can generally be ruled out in the glacier mummy.On the basis
of the previous studies mentioned, the Iceman was walking
intensively in the mountain area, he had a slim and well-
trained body, and his nutrition was well-balanced with low
amounts of proteins and saturated fats. Tobacco was not
available in that time period, although dark staining in his
lungs indicate that he inhaled smoke during his life, most
likely from open campfires. Whether campfire smoke has a
similar impact as tobacco smoke does on atherosclerotic dis-
ease is currently not known. Studieswith animalmodels have,
however, shown an interaction between wood fire exposure
and the development of atherosclerosis [45]. This potential is
further reviewed by Thomas et al. in this issue [46].
In the genome study of the Iceman, the investigators
specifically concentrated on genetic risk factors that are
linked with cardiovascular disease in genome-wide asso-
ciation studies (Table 1). The sequencing data demon-
strates that the Iceman was homozygous for the minor
allele (GG) of rs10757274, located in chromosomal region
9p21. This SNP is currently regarded as being among the
strongest genetic predictors of myocardial infarction and
has been confirmed in several studies as a major risk locus
for CHD. In the CCHS (Copenhagen City Heart Study) and
in the ARIC (Atherosclerosis Risk in Communities Study),
an up to 40% increased risk for development of clinically
manifested CHD in different ethnicities was found, inde-
pendent of other classical risk factors [25]. Additionally,
the rs10757274 SNP was described as a major risk
locus for ischemic stroke and sudden cardiac death (meta-
analysis of 6 independent cohort studies) [26,47,48]. The
SNP analysis of the Iceman genome further revealed a
homozygous minor allele of rs2383206 (GG), located in
9p21, representing another major risk factor for CHD [49].
The presence of both of the 9p21 SNP almost doubles the
risk for developing CHD [50]. The Iceman’s genome harbors
further SNP that were related to cardiovascular disease, such
as the endothelin receptor type B heterozygote variant
rs5351 on chromosome 13. Yasuda et al. [51] showed that
this SNP independently increases the risk for atherosclerosis
in men. Additionally, the analysis revealed SNP in 3 genes
that have been associated with CHD, namely VDR, TBX5,
and BDKRB1. Whereas Keller et al. [11] detected the SNP
rs2228570, located in a start codon of the gene VDR, for
genes TBX and BDKRB1, novel mutations that have caused
changes in the respective stop codons were found.
FUTURE STUDIES OF DNA IN ANCIENT MUMMIES
Until now, the Iceman is the only ancient human remain in
which a genetic predisposition for cardiovascular disease has
been detected. Although an increasing number of whole
genome studies are being performed, dating back to Nean-
derthals and early hominins [19,52,53], no other similar
detailed SNP analysis regarding these risk factors has been
performed. In addition, in skeletal samples, a comparison
with the phenotype, the actual presence of calcified arteries,
is not possible due to the lack of soft tissue preservation.
Therefore, the comparison of phenotype and genotype
regarding cardiovascular disease as shown in the Iceman
represents a unique opportunity for interdisciplinary study.FIGURE 6. Reconstruction of the Iceman.
FIGURE 5. Three-dimensional CT reconstruction of the
Iceman. The stone arrowhead is visible at the left
shoulder region.
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Several studies of the Horus Team revealed a high inci-
dence of arterial calcifications in mummies from various
geographic origins and time periods [29,30]. To evaluate the
presence of genetic predispositions in thesemummies, further
studies are planned that will include a detailed SNP analysis of
cardiovascular risk factors and possible identification of new
or currently unrecognized genetic polymorphisms that are no
longer present in modern-day patients. For this, full genome
sequences should be obtained from the mummies (Fig. 7).
However, the likelihood of success of such attempts depends
heavily on the state of preservation of genomic DNA in the
various mummies. The Iceman is exceptionally well pre-
served, probably due to the deposition in a cold and stable
environment for more than 5,000 years. In other mummies,
such as those from hot climates as present in Egypt or the
desert areas of South America, DNAdegradationmay hamper
potential SNP analysis. On the other hand, it has to be taken
into account that the fast and efficient desiccation of the
TABLE 1. SNP related to cardiovascular disease identified in the Iceman genome
Chr. dbSNP#
1,000 Genomes minor
allele frequency Gene
Coverage Iceman
A C G T N SNP association
chr1 rs1801133 A ¼ 0.325 MTHFR 10 0 1 0 0 Cardiovascular disease
chr1 rs1764391 T ¼ 0.354 GJA4 0 4 0 9 0 Atherosclerosis
chr4 rs1870377 A ¼ 0.241 KDR 8 0 0 9 0 Coronary heart disease
chr9 rs10757274 G ¼ 0.396 CDKNBAS 1 0 8 0 0 Ischemic stroke, sudden cardiac death
chr9 rs2383206 G ¼ 0.459 CDKNBAS 0 0 8 0 0 Coronary heart disease
chr13 rs5351 T ¼ 0.436 EDNRB 0 14 0 20 1 Atherosclerosis
chr19 rs1613662 G ¼ 0.141 GP6 4 0 3 0 0 Myocardial infarction, age
chr, chromosome; dbSNP, single nucleotide polymorphism database; SNP, single nucleotide polymorphisms.
FIGURE 7. Setup of the ancient DNA laboratory at the Institute for Mummies and the Iceman in Bolzano, Italy.
Samples are processed in a specific 1-way workflow following strict rules to avoid any contamination.
gREVIEWj
GLOBAL HEART, VOL. 9, NO. 2, 2014 207
June 2014: 203-209
ancient Egyptian mummies during the mummification pro-
cess, including the wrapping and embalming, may be factors
that helped to slow down the natural DNA degradation pro-
cess. In a few studies, it has been suggested that genomicDNA
can be retrieved from Egyptian mummies [10,54]. Further
studies are required to evaluate the possibility of obtaining full
genomes from those mummies.
SUMMARY
Twenty-first century humans often think that much of the
heart disease we suffer is the consequence of our modern
lifestyle.We live sedentary, mentally stressful lives, consume
large amounts of calories from ill-chosen foods, indulge
sugar and salt in high quantities, and are exposed to high
levels of environmental toxins, including tobacco smoke. To
avoid dying of a heart attack, we are urged to engage in
regular exercise; maintain an ideal body weight; avoid un-
saturated fat, salt, and sugar; avoid smoke; and takemedicine
to keep our blood pressure, lipid levels, and blood sugar in
an ideal range. Perhaps we think nostalgically of our ances-
tors who lived a purer life and did not have to engage in
corrective actions to prevent heart disease.
Wrong! Our ancestors going back thousands of years
show signs of atherosclerosis, as suggested by modern
research using CT to detect evidence of calcium deposits
associated with atherosclerotic plaques in the arteries of
mummies as old as 5,000 years. Even though our human
ancestors lived far different lives than we do, their environ-
ments and lifestyles were not protecting them against the
development of atherosclerosis.
What is similar between now and then is the human ge-
neticmaterial, our genome, including ancient polymorphisms
that were uncovered to predispose the carrier to the devel-
opment of atherosclerotic cardiovascular disease. Seminal
studies of genetic material obtained from 5,300-year-old Ötzi
showedmutations in the 9p21 chromosomal region identical
to SNP identified in contemporary humans that are strong
predictors for the development ofCAD.Our ancient ancestors
were certainly susceptible to many other conditions, such
as infectious diseases, nutritional deprivation, and trauma,
which often resulted in an early age death, before athero-
sclerotic heart disease became clinically manifest.
Nevertheless, the study of ancient humans and the
investigation of the interaction between environmental and
genetic influences on the development of heart disease may
provide unique pathophysiologic insights and lead to more
effective prevention and treatment of the most common
cause of death in the modern world.
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